Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to assess the safety and tolerability of rifaximin 600 mg (3 x 200-mg tablets) once daily compared with placebo when taken for 14 days by healthy subjects to pre...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bausch Health Americas, Inc.
NCT07196410 · Colitis, Diarrhea Caused by Antitumor Drugs
NCT04038619 · Colitis, Diarrhea, and more
NCT06237452 · Clostridium Difficile, Clostridium Difficile Infections, and more
NCT07087054 · Carcinoid Syndrome, Carcinoid, and more
NCT07338565 · Colitis Ulcerosa, Colitis Ulcerative, and more
Sunshine Medical Center
South Miami, Florida
Southwest Doctors, PA
Houston, Texas
La Porte Family Clinic
La Porte, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions